NASDAQ:SPRO | EBITDA Margin | Spero Therapeutics, Inc.

Complete source-backed ebitda margin history.

Available history
2016-12-31 to 2025-12-31
Data captured

Historical EBITDA Margin

DateEBITDA Margin
2025-12-31249.76%
2024-12-31-41778.85%
2024-03-31-9987.14%
2023-12-3122677.13%
2023-03-31-6329.15%
2022-12-319371.58%
2022-03-31-12153.04%
2021-12-31-10668.36%
2021-03-31-263.62%
2020-03-31-13391.72%
2019-12-31-3734.77%
2019-03-31-144.79%
2018-12-31-646.87%
2018-03-31-929.84%
2017-12-31-1399.90%

Annual EBITDA Margin

DateEBITDA Margin
2025-12-3150.17%
2024-12-31-19773.32%
2023-12-312341.69%
2022-12-31-1651.14%
2021-12-31-2844.46%
2020-12-31-30368.99%
2019-12-31-1317.29%
2018-12-31-1069.01%
2017-12-31-2090.30%
2016-12-31-9833.43%

Research interface only. Not investment advice. Prices are a checked-in snapshot, not live quotes.